Hugel launches Letybo in Malaysia, targeting Southeast Asia
Hugel officially launched Letybo, a botulinum toxin product, in Malaysia. The company held events at AMSC and in Kuantan to introduce the product to local medical professionals.
Hugel reports record 2025 revenue of 425.1 billion won
Hugel reported record 2025 revenue of 425.1 billion won, up 14% year-over-year. Operating profit rose 21.3% to 201.6 billion won. Growth driven by global expansion of botulinum toxin and filler products.
Hugel strengthens partnership in Brazil for botulinum toxin market
Hugel partners with Derma Dream in Brazil to target Latin American botulinum toxin market. Pre-launch events for 'Letybo' held in Rio de Janeiro and São Paulo.
JPMorgan: Crypto Market Structure Act likely to pass mid-year
JPMorgan predicts the Crypto Market Structure Act will likely pass by mid-2026, potentially transforming the crypto market and attracting institutional investors.
Get full access to view complete information
1 - 5 of 5
Get full access to view complete information
Frequently Asked Questions Regarding HUGEL ET FILS SA
Company Overview
1639
Founded
Food Production
Industry
France
Location
6,785,650
Ranking
13 employees
Size
Similar Companies
Get full access to view complete information
Frequently Asked Questions Regarding HUGEL ET FILS SA
Start your journey today
Start with the platform — or start with a conversation
Use Pubrio on your own, or let our team help you with research, lead generation, or data integration.